✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

SMS Pharmaceuticals Ltd.

SMSPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹2,682 Cr.
P/E
31.79

SMS Pharmaceuticals Ltd.

  • SMS Pharmaceuticals
  • Solara Active Pharma
  • IOL Chem & Pharma
  • TJI Pharma - Small Cap

FAQs on SMS Pharmaceuticals Ltd. Shareprice

SMS Pharmaceuticals has given better returns compared to its competitors.
SMS Pharmaceuticals has grown at ~23.07% over the last 7yrs while peers have grown at a median rate of 15.75%

Yes, SMS Pharmaceuticals is expensive.
Latest PE of SMS Pharmaceuticals is 32.11, while 3 year average PE is 25.18.
Also latest EV/EBITDA of SMS Pharmaceuticals is 18.14 while 3yr average is 18.08.

View FAQ's On Business

Growth Table

  • SMS Pharmaceuticals Ltd.
  • Solara Active Pharma
  • IOL Chem & Pharma

Balance Sheet

  • SMS Pharmaceuticals Ltd.
  • Solara Active Pharma
  • IOL Chem & Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • SMS Pharmaceuticals Ltd.
  • Solara Active Pharma
  • IOL Chem & Pharma

Cash Flow

  • SMS Pharmaceuticals Ltd.
  • Solara Active Pharma
  • IOL Chem & Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • SMS Pharmaceuticals Ltd.
  • Solara Active Pharma
  • IOL Chem & Pharma

Quarterly Results

  • SMS Pharmaceuticals Ltd.
  • Solara Active Pharma
  • IOL Chem & Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on SMS Pharmaceuticals Ltd. Financials

Balance sheet of SMS Pharmaceuticals is strong.
But short term working capital might become an issue for this company.

The net debt of SMS Pharmaceuticals is decreasing.
Latest net debt of SMS Pharmaceuticals is ₹225 Crs as of Sep-25.
This is less than Mar-25 when it was ₹228 Crs.

Yes, profit is increasing.
The profit of SMS Pharmaceuticals is ₹81.01 Crs for TTM, ₹69.14 Crs for Mar 2025 and ₹49.83 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
SMS Pharmaceuticals latest dividend payout ratio is 5.13% and 3yr average dividend payout ratio is 5.96%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech